Albert David Q3 Results
- BSE: 524075
- NSE: ALBERTDAVD
- ISIN: INE155C01010
- Sector: Biotechnology & Drugs
BSE
809.20
1.50 (0.19%)
1.50 (0.19%)Volume274.00
Updated: Mon 17 Aug, 2026 | 15:17:28
NSE
805.00
-7.50 (-0.92%)
-7.50 (-0.92%)Volume9.57 K
Updated: Mon 17 Aug, 2026 | 15:29:39
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Albert David Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 81.53 | 93.88 | -6.22% | 81.61 | -3.07% |
| Depreciation/ Amortization | 2.42 | 1.67 | 8.76% | 1.68 | 42.83% |
| Operating Income | 8.40 | 4.55 | 2589.15% | 6.67 | 0.00% |
| Net Income | 15.30 | 18.07 | 0.00% | 18.72 | 0.00% |
| Other Operating Expenses Total | 27.37 | 32.58 | 1.48% | 24.04 | -0.34% |
| Net Income Before Taxes | 19.90 | 25.13 | 0.00% | 23.44 | 0.00% |
| Total Revenue | 89.93 | 98.44 | 3.08% | 88.28 | 8.24% |
| Selling/ General/ Admin Expenses Total | 23.90 | 29.31 | -11.73% | 23.09 | -16.47% |
| Diluted Normalized EPS | 26.81 | 31.67 | 0.00% | 32.80 | 0.00% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.